Research

Research

The CPDC is engaged in de novo probe development. Specializing in oncology, the CPDC works with its industrial partners to develop novel agents for early disease detection, staging and assessment of new therapeutics.

The CPDC facilities in Hamilton, Ontario, meet the needs of both research and industry, helping the two work towards the common goal of getting promising molecular imaging probes and associated products and services into hospitals and clinics in Canada and around the world.

Over the past five years, Canadian federal and Ontario provincial funding agencies have invested more than $50 million in molecular imaging and basic probe research in Ontario alone.

Right now, many groups in Canada are involved in some stage of research, but most lack the resources – facilities, funding or expertise – to move their products down the development pipeline towards commercialization and clinical application. The CPDC also has a role in helping researchers in Canada commercialize their probe IP.

An annual Open Call for Proposals provides the Centre an opportunity to open its doors to the most promising probe research in Canada, bridging the gap between research and clinical application.